BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27662647)

  • 1. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
    Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens.
    Sammour MB; el-Kabarity H; Fawzy MM; Schindler AE
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):439-40. PubMed ID: 16236493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogens in the prevention of miscarriage.
    Carp HJ
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):55-62. PubMed ID: 26677905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case.
    Tskhay VB; Kovtun NM; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):85-8. PubMed ID: 27383893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of dydrogesterone for the treatment of threatened miscarriage.
    Carp H
    Gynecol Endocrinol; 2012 Dec; 28(12):983-90. PubMed ID: 22794306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dydrogesterone and pre-term birth.
    Hudic I; Schindler AE; Szekeres-Bartho J; Stray-Pedersen B
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):81-3. PubMed ID: 26812800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth.
    Alizadeh F; Mahmoudinia M; Mirteimoori M; Pourali L; Niroumand S
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):167. PubMed ID: 35232423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone in normal and pathological pregnancy.
    Di Renzo GC; Giardina I; Clerici G; Brillo E; Gerli S
    Horm Mol Biol Clin Investig; 2016 Jul; 27(1):35-48. PubMed ID: 27662646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dydrogesterone in the reduction of recurrent spontaneous abortion.
    El-Zibdeh MY
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
    Wang S; Wang XT; Liu RH; Liu M; Wu YR; Huang XY; Zhao N; Mu YL
    Ginekol Pol; 2017; 88(12):679-685. PubMed ID: 29303226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
    Kuptarak A; Phupong V
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
    Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia.
    Ali AB; Ahmad MF; Kwang NB; Shan LP; Shafie NM; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):93-6. PubMed ID: 26910749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New data about preeclampsia: some possibilities of prevention.
    Schindler AE
    Gynecol Endocrinol; 2018 Aug; 34(8):636-637. PubMed ID: 29508649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.